Liu Q, Li J, Chen H, Song J, et al. Letter to the Editor: Hepatic decompensation is the major driver of mortality in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: The impact of successful antiviral treatment. Hepatology 2025 Jan 31. doi: 10.1097/HEP.0000000000001215.
PMID: 39928566